| Value | ₹200.0 Cr |
|---|---|
| Execution period | 21 months |
NSE filing, NSE: TATVA. Summary written from the filing by ALFA Finder's alert engine.
Tatva Chintan Pharma Chem Ltd: key numbers
- Share price
- ₹1,661.80
- Market cap
- ₹3,887 Cr
- Revenue (annual)
- ₹505.9 Cr
- Net profit (annual)
- ₹42.05 Cr
- P/E (TTM)
- 61.8×Sector 33.6×
- Promoter holding
- 72.02%+0.00% QoQ
- FII holding
- 4.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tatva Chintan Pharma Chem Ltd
All →Tatva Chintan Pharma Chem Investor Presentation: Key Takeaways
Tatva Chintan reported record quarterly revenue of ₹2,173 Mn for Q2 FY27, up 76% YoY, driven by strong SDA demand. EBITDA margins remained flat at 19% due to high solvent costs and freight spikes.
Tatva Chintan Pharma Chem Q2 FY27 Results: Net Profit ₹21.5 Cr, Up 117.2% YoY
Tatva Chintan Pharma Chem Ltd reported revenue from operations of ₹217.3 Cr (+76.0% YoY) and net profit of ₹21.5 Cr (+117.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹21.5 Cr · +117.2% YoY
Tatva Chintan Pharma Chem Other Announcement
The company has filed its quarterly shareholding pattern as per SEBI regulations. This routine disclosure provides details on the current shareholding structure.
Tatva Chintan Pharma Chem Board Meeting Date
Tatva Chintan Pharma Chem has scheduled a Board meeting for 19 October 2026 to consider Q1 FY27 financial results. The trading window will remain closed until 48 hours after results are published.
Tatva Chintan Pharma Chem Annual General Meeting
The company held its 30th Annual General Meeting on September 25, 2026. Shareholders considered and approved items including financial statements and director re-appointments.
Tatva Chintan Pharma Chem Credit Rating
CRISIL Ratings upgraded Tatva Chintan's long-term bank facilities to CRISIL A-/Stable and short-term facilities to CRISIL A2+. This upgrade reflects the company's improved credit profile.
Other capacity expansion announcements
All →Kaynes Technology India Capacity Expansion
Kaynes Technology has incorporated a wholly owned subsidiary, Kaynes Arabia Electronics Company, in Saudi Arabia to manufacture electronic products for GCC markets. The company holds 100% ownership and the authorised share capital is SAR 100,000.
Vaibhav Vyapaar Capacity Expansion
Vaibhav Vyapaar opened a new business office in Bangalore, commencing operations on 02 November 2026. The approximately 5,500 sq ft office supports operational expansion.
- office area
- 5500.0 sq ft
Borana Weaves Capacity Expansion: ₹49.92 Cr Investment
Borana Weaves plans 384 new looms, adding 110.60 million metres of yearly capacity. The Rs 49.92 Crore investment will be phased through March 2027.
- Value
- ₹49.92 Cr
- Execution
- Phase 1 by December 2026; Phase 2 by March 2027
- annual greige fabric production capacity
- 110.6 million metres per year
Sita Enterprises Capacity Expansion
Sita Enterprises' board approved changing its main object to investment, lending and financial services. Name change and new MOA/AOA also await shareholder approval via postal ballot.
Trident Capacity Expansion: ₹4,650 Cr Investment
Trident's board approved a Rs 4,650 Crore capacity expansion across yarn, sheeting, paper and renewable energy. Completion is due between 2027 and 2029.
- Value
- ₹4,650 Cr
- Execution
- Completion between December 31, 2027 and September 30, 2029, by segment
Borana Weaves Capacity Expansion
Borana Weaves approved adding 384 water jet looms at Unit 4, expanding annual greige fabric capacity by about 110.6 million metres. Completion is targeted by March 2027.
- Execution
- Phase 1 by December 2026; Phase 2 by March 2027
- annual greige fabric production capacity
- 110.6 million metres